World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
86
Citations
52889
World Ranking
13844
National Ranking
7028

Thomas R. Fleming publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Thomas R. Fleming sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 263 publications — 10th percentile

10% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Thomas R. Fleming D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Thomas R. Fleming sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 86 D-Index — 31st percentile

31% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Research.com Recognitions

  • 2012 - Member of the National Academy of Medicine (NAM)
  • 1987 - Fellow of the American Statistical Association (ASA)

Overview

Thomas R. Fleming is affiliated with the University of Washington in the United States. Their research primarily focuses on the field of Medicine, with significant contributions in Infectious Diseases, Statistics and Probability, Economics and Econometrics, Health, and Oncology.

Their scholarly work addresses a range of topics including:

  • SARS-CoV-2 and COVID-19 Research
  • Statistical Methods in Clinical Trials
  • Vaccine Coverage and Hesitancy
  • Health Systems, Economic Evaluations, Quality of Life
  • COVID-19 Clinical Research Studies
  • Ethics in Clinical Research
  • Viral Infections and Outbreaks Research

Frequent collaboration partners for Thomas R. Fleming include:

  • Ira M. Longini
  • Philip R. Krause
  • Martha Nason
  • Ana María Henao-Restrepo
  • Ying Huang

Their research articles have been published notably in venues such as:

  • Clinical Trials
  • UNC Libraries
  • New England Journal of Medicine
  • The Lancet
  • Annals of Internal Medicine

Selected recent papers authored or coauthored by Thomas R. Fleming include:

  • Conducting Clinical Research During the COVID-19 Pandemic, 2020, JAMA
  • SARS-CoV-2 Variants and Vaccines, 2021, New England Journal of Medicine
  • COVID-19 vaccine trials should seek worthwhile efficacy, 2020, The Lancet
  • Clinical Endpoints for Evaluating Efficacy in COVID-19 Vaccine Trials, 2020, Annals of Internal Medicine
  • Placebo-Controlled Trials of Covid-19 Vaccines - Why We Still Need Them, 2020, New England Journal of Medicine

Thomas R. Fleming has received recognition from professional bodies, including being named a Member of the National Academy of Medicine in 2012 and a Fellow of the American Statistical Association in 1987.

Best Publications

  • Prevention of HIV-1 Infection with Early Antiretroviral Therapy

    Myron S. Cohen;Ying Q. Chen;Marybeth McCauley;Theresa Gamble

  • A multiple testing procedure for clinical trials.

    Peter C. O'Brien;Thomas R. Fleming

  • Sildenafil citrate therapy for pulmonary arterial hypertension.

    Nazzareno Galiè;Hossein A. Ghofrani;Adam Torbicki;Robyn J. Barst

  • Levamisole and Fluorouracil for Adjuvant Therapy of Resected Colon Carcinoma

    Moertel Cg;Fleming Tr;Macdonald Js;Haller Dg

  • A class of rank test procedures for censored survival data

    David P. Harrington;Thomas R. Fleming

  • Martingale-based residuals for survival models

    Terry M. Therneau;Patricia M. Grambsch;Thomas R. Fleming

  • Targeted Anticytokine Therapy in Patients with Chronic Heart Failure: Results of the Randomized Etanercept Worldwide Evaluation (RENEWAL)

    Douglas L. Mann;John J.V. McMurray;Milton Packer;Karl Swedberg

  • One-Sample Multiple Testing Procedure for Phase II Clinical Trials

    Thomas R. Fleming

  • Fluorouracil plus Levamisole as Effective Adjuvant Therapy after Resection of Stage III Colon Carcinoma: A Final Report

    Charles G. Moertel;Thomas R. Fleming;John S. Macdonald;Daniel G. Haller

  • Prognosis in primary biliary cirrhosis: model for decision making.

    E R Dickson;P M Grambsch;T R Fleming;L D Fisher

  • Surgical adjuvant therapy of large-bowel carcinoma: an evaluation of levamisole and the combination of levamisole and fluorouracil. The North Central Cancer Treatment Group and the Mayo Clinic.

    J A Laurie;C G Moertel;T R Fleming;H S Wieand

  • Primary sclerosing cholangitis: Natural history, prognostic factors and survival analysis

    Russell H. Wiesner;Patricia M. Grambsch;E. Rolland Dickson;Jurgen Ludwig

  • Addition of Sildenafil to Long-Term Intravenous Epoprostenol Therapy in Patients with Pulmonary Arterial Hypertension: A Randomized Trial

    Ge rald Simonneau;Lewis J. Rubin;Nazzareno Galie;Robyn J. Barst

  • High-dose vitamin C versus placebo in the treatment of patients with advanced cancer who have had no prior chemotherapy. A randomized double-blind comparison.

    Charles G. Moertel;Thomas R. Fleming;Edward T. Creagan;Joseph Rubin

  • Estimating the proportion of treatment effect explained by a surrogate marker

    Danyu Lin;T. R. Fleming;V. De Gruttola

  • An Evaluation of the Carcinoembryonic Antigen (CEA) Test for Monitoring Patients With Resected Colon Cancer

    Charles G. Moertel;Thomas R. Fleming;John S. Macdonald;Daniel G. Haller

  • A Comparison of Three Chemotherapeutic Regimens in the Treatment of Advanced Pancreatic and Gastric Carcinoma: Fluorouracil vs Fluorouracil and Doxorubicin vs Fluorouracil, Doxorubicin, and Mitomycin

    Stephen A. Cullinan;Charles G. Moertel;Thomas R. Fleming;Joseph R. Rubin

  • Pediatric Pulmonary Hypertension

    D. Dunbar Ivy;Steven H. Abman;Robyn J. Barst;Rolf M.F. Berger

  • Efficacy of nonoxynol 9 contraceptive sponge use in preventing heterosexual acquisition of HIV in Nairobi prostitutes.

    Joan Kreiss;Elizabeth Ngugi;King Holmes;Jeckoniah Ndinya-Achola

  • Phase II study of fluorouracil and its modulation in advanced colorectal cancer: a Southwest Oncology Group study.

    C G Leichman;T R Fleming;F M Muggia;C M Tangen

Frequent Co-Authors

David L. DeMets
David L. DeMets University of Wisconsin–Madison
Jean B. Nachega
Jean B. Nachega University of Pittsburgh
Stein Emil Vollset
Stein Emil Vollset University of Washington
Zulfiqar A Bhutta
Zulfiqar A Bhutta Aga Khan University
Bach Xuan Tran
Bach Xuan Tran Vietnam National University, Hanoi
Ferrán Catalá-López
Ferrán Catalá-López Instituto de Salud Carlos III
Juan Sanabria
Juan Sanabria Marshall University
Cyrus Cooper
Cyrus Cooper University of Southampton
Alan D. Lopez
Alan D. Lopez University of Melbourne
Ted R. Miller
Ted R. Miller Pacific Institute

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

The journey to becoming a doctor is just one way to contribute to the healthcare field. Many students choose alternative pathways that offer rewarding careers and valuable skills. If you are interested in the operational side of medicine, consider a health care administration online degree. These programs can prepare you for leadership roles in hospitals, clinics, and public health organizations.

Advancing your education doesn’t have to break the bank. There are options for cheap mha programs that provide a cost-effective route to a master’s degree in healthcare administration. For those aiming at advanced practice, the cheapest online dnp programs help nurses expand their clinical expertise and impact patient outcomes.

Students also explore careers in pharmacy, a crucial branch of medicine. Enrolling in the best online pharmacy school can open up opportunities in clinical, research, and pharmaceutical industry settings. These alternatives give you flexibility, affordability, and a broad range of options for a meaningful medical career.

Best Scientists Citing Thomas R. Fleming

Trending Scientists

Recently Published Articles